Scripps Translational Science Institute

Download the Syllabus here - 132 pages

Dear Colleague,

We invite you to another exciting day and a half program on Friday, March 5 and Saturday, March 6, 2010 in beautiful San Diego, California. Once again, this year's program will be held at The Neurosciences Institute Auditorium.

As you will see in the enclosed program, we are inviting a dynamic group of speakers who will cover a wide range of topics. Presentations will focus around the whole genomic sequencing of people during the Friday afternoon session and will be followed by our annual evening welcome reception at Scripps Translational Science Institute. On Saturday, we are excited to host the distinguished Dr. Leroy Hood as our keynote speaker. Dr. Hood is recognized as one of the world’s leading scientists in molecular biotechnology and genomics. Dr. Hood will address the group on The Future of Genomic Medicine.

Our goal is to continue to examine the salient progress and challenges in the field of genomics that will change medicine with concise presentations allowing ample time for interactive panel and participant discussions following each topic series.

We look forward to your participation and another successful conference,

Eric J. Topol, M.D. and Robert L. Strausberg, Ph.D.
Course Co-Directors

Educational Objectives

• Demonstrate the unmet needs of medicine today with respect to more targeted, individualized prevention and treatments.
• Discuss the opportunities of the genome, proteome, metabolome discovery to change medical practice as it exists today.
• Assess how changes and advances in technology are rapidly ushering in a whole array of new pathways for individualized medicine of the future.
• Explore specific strategies in cancer, cardiovascular and pharmacogenomic interventions.

Who Should Attend?

• Human geneticists
• Genomic scientists
• Researchers
• Physicians
• Health care professionals of all disciplines interested in the future of medicine, especially with respect to individualized therapies.

Scripps Translational Science Institute

Scripps Translational Science Institute (STSI), a bridge between the Scripps Health organization and The Scripps Research Institute, is transforming and integrating clinical and basic research by promoting interdisciplinary omics-based translational research efforts which advance the field of individualized personalized medicine. STSI is supported by the NIH flagship program, Clinical and Translational Science Award (CTSA). Besides Scripps, there are collaborations with the Burnham Institute for Medical Research, Children’s Hospital of Philadelphia, Genomics Institute of the Novartis Research Foundation, J. Craig Venter Institute, Salk Institute for Biological Studies, San Diego State University, San Diego Supercomputer Center and The Neurosciences Institute on the San Diego Mesa. The Institute emphasizes three dimensions of translation: i) traditional bench-to- bedside, ii) bedside-to-bench and back-to-bedside, and iii) bedside to the community medicine. STSI harnesses the excitement of today’s scientific advances to catapult tomorrow’s preventions, betterment of health, and the training of future leaders of academic medicine. For more information on Scripps Health, visit http://www.scripps.org. For more information on The Scripps Translational Science Institute (STSI), visit http://www.stsiweb.org.

The J. Craig Venter Institute

The JCVI is a not-for-profit research institute in Rockville, MD and La Jolla, CA dedicated to the advancement of the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policymakers. Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 400 scientists and staff with expertise in human and evolutionary biology, genetics, bioinformatics/informatics, information technology, high-throughput DNA sequencing, genomic and environmental policy research, and public education in science and science policy. The legacy organizations of the JCVI are: The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA), the Joint Technology Center (JTC), and the J. Craig Venter Science Foundation. The JCVI is a 501 (c) (3) organization. For more information on the J. Craig Venter Institute, visit http://www.JCVI.org.